Noël-Savina E, Paleiron N, Le Gal G, Descourt R
Service d'oncologie thoracique, CHU Morvan, CHU de Brest, 3, avenue Foch, 29200 Brest, France.
J Mal Vasc. 2012 Jun;37(3):146-9. doi: 10.1016/j.jmv.2012.02.003. Epub 2012 Apr 7.
Septic thrombophlebitis on a central venous access device (CVAD) is a rare and serious complication. According to current guidelines, the device should be removed and antibiotics be given. The risk of septic thrombophlebitis is related to the migration of septic emboli to the lung, a potentially fatal event, particularly in frail patients with lung cancer. We report a case observed in a 66-year-old man with multiple metastatic lung cancer who had a CVAD and who developed septic thrombophlebitis leading to coagulase-negative staphylococcal bacteriemia. After removal of the CVAD, the thrombophlebitis was complicated by pulmonary embolism affecting the entire network of the right lung.
中心静脉通路装置（CVAD）相关的脓毒性血栓性静脉炎是一种罕见且严重的并发症。根据现行指南，应移除该装置并给予抗生素治疗。脓毒性血栓性静脉炎的风险与脓毒性栓子迁移至肺部有关，这是一个潜在的致命事件，尤其在患有肺癌的体弱患者中。我们报告了一例66岁的男性多发转移性肺癌患者，该患者有CVAD并发生了脓毒性血栓性静脉炎，导致凝固酶阴性葡萄球菌菌血症。在移除CVAD后，血栓性静脉炎并发肺栓塞，累及右肺的整个肺血管网。
